| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Oligonucleotide |
| Molecule Category: | Parent |
| UNII: | F60NE4XB53 |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Primary Myelofibrosis | 3 | D055728 | ClinicalTrials |
| Primary Myelofibrosis | 3 | D055728 | ClinicalTrials |
| Myelodysplastic Syndromes | 2 | D009190 | ClinicalTrials |
| Thrombocythemia, Essential | 2 | D013920 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Polycythemia Vera | 2 | D011087 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Neuroblastoma | 1 | D009447 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
Related Entries
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 868169-64-6 |
| ChEMBL | CHEMBL2107856 |
| FDA SRS | F60NE4XB53 |
| PubChem | 71587831 |
CONTENTS